News

FDA cracking down on Ozempic copycats, potentially slimming options for consumers
The Food and Drug Administration is cracking down on copycat versions of Ozempic — the brand name of semaglutide — and ...
The New York Sun4d
Millions of Americans Face Sticker Shock From Weight Loss Drugs as FDA Bars Production of Cheaper Versions of Ozempic, Others
Compounding pharmacies, that produced the weight loss drugs at a fraction of their brand name price, are being forced to stop ...
Ozempic Knockoffs Survive Crackdown Thanks to Loophole
Providers of compounded obesity drugs are finding—for now—a new way into the booming market by tweaking formulations.
Wegovy maker Novo faces fee demand after losing copycat drug lawsuit
(Billable Hours is Reuters' weekly report on lawyers and money. Please send tips or suggestions to ...
Maker of Ozempic and Wegovy broke advertising rules, regulator finds
The maker of weight loss drugs Ozempic and Wegovy broke rules around the advertising and marketing of its medication to ...
Omaha doctor weighs in on FDA cracking down on some third party weight loss medications
The FDA is cracking down on off brand weight loss products similar to Ozempic. GLP-1 drugs for weight loss like Wegovy or ...
Endocrinology Advisor1d
FDA Halts Sale of Off-Brand Ozempic and Other GLP-1 Drugs
A federal deadline ending the sale of off-brand weight-loss and diabetes medications is now in effect, cutting off access to drugs many patients count on.
STAT9d
Pharmalittle: We’re reading about FDA eyeing PDUFA changes, compounded weight loss drugs, and more
Online weight loss company Noom has begun offering smaller doses of compounded versions of Novo Nordisk's Wegovy ...
Becker's Hospital Review10d
Companies sidestep FDA deadline on Ozempic copies
An FDA deadline instructing compounding pharmacies and telehealth companies to stop selling compounded versions of Ozempic and Zepbound has not stopped the copycat market, The Wall Street Journal ...